Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: A narrative review

37Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.

Abstract

Obesity and obesity-associated kidney injuries have played an important role in the rising prevalence of chronic kidney disease (CKD). The link between obesity and kidney disease begins with obesity's well-known associations with diabetes and hypertension, the two leading etiologies of CKD. However, a growing body of evidence suggests that elevated aldosterone levels and expanded extracellular volume are key components of obesity-induced renal disease via aldosterone's non-epithelial effects on the kidney. Highlighting these blood pressure- and diabetes-independent mechanisms of kidney injury in obesity allows an exploration of whether mineralocorticoid receptor blockade, coupled with weight loss and salt restriction, is an optimal treatment for overweight CKD patients. Copyright © 2009 S. Karger AG.

Cite

CITATION STYLE

APA

Bomback, A. S., & Klemmer, P. J. (2009, August). Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: A narrative review. American Journal of Nephrology. https://doi.org/10.1159/000209744

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free